TNF and melanoma: Studies have shown that administration of TNF-α as an immunotherapy has resulted in high levels of toxicity, but localized delivery in isolated limb perfusion showed anti-tumor abilities in soft tissue sarcomas, melanoma, and hepatocellular carcinoma (111, 120).